AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Digital Healthcare Stocks Poised for a Breakout: Oscar and Hims & Hers Health Leading the Way
ByAinvest
Friday, Jul 25, 2025 4:25 am ET1min read
Two digital healthcare stocks, Oscar Health and Hims & Hers Health, are poised for a breakout despite recent challenges. Oscar Health reported a 42% YoY revenue increase to $3 billion and a 55% profit growth, while Hims & Hers Health saw a 111% YoY revenue surge to $586 million. However, Oscar Health faces cost pressure and volatility, and Hims & Hers Health is navigating regulatory scrutiny and partnership disputes. Both companies have scalable technology models and massive total addressable markets, making them potential long-term investment opportunities.
Two digital healthcare stocks, Oscar Health, Inc. (OSCR) and Hims & Hers Health, Inc. (HIMS), are poised for a breakout despite recent challenges. Oscar Health reported a 42% year-over-year (YoY) revenue increase to $3 billion and a 55% profit growth, while Hims & Hers Health saw an 111% YoY revenue surge to $586 million [1].However, Oscar Health faces cost pressure and volatility. The company closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day [1]. Despite this, Oscar Health is expected to report an earnings per share (EPS) of -$0.51, showcasing a 355% downward movement from the corresponding quarter of the prior year. The company's Zacks Rank is currently at #4 (Sell), indicating a cautious outlook [1].
On the other hand, Hims & Hers Health has been trading up by 15.56% following positive sentiment from noteworthy strategic partnerships. The company's stock has gained 1.6% in the latest trading session, setting the market abuzz with expectations of more positive outcomes [2]. The company is set to expand to Canada by 2026, introducing generic semaglutide, a key ingredient in weight-loss treatments. However, the company is navigating regulatory scrutiny and partnership disputes, which could pose hurdles to its growth [2].
Both companies have scalable technology models and massive total addressable markets, making them potential long-term investment opportunities. Despite their challenges, investors should keep a close eye on these companies as they continue to innovate and expand in the digital healthcare space.
References:
[1] https://www.nasdaq.com/articles/oscar-health-inc-oscr-stock-declines-while-market-improves-some-information-investors-0
[2] https://stockstotrade.com/news/hims-hers-health-inc-hims-news-2025_07_23/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet